Pharmabiz3h
Enanta Pharma announces top-line results for EDP-323 in phase 2a human challenge study of healthy adults infected with RSV
Watertown, Massachusetts Saturday, September 28, 2024, 18:00 Hrs [IST] ...
Pharmabiz4h
PTC Therapeutics’ PTC518 Huntington's disease programme receives US FDA Fast Track Designation
PTC Therapeutics’ PTC518 Huntington's disease programme receives US FDA Fast Track Designation: Warren, New Jersey Saturday, September 28, 2024, 17:00 Hrs [IST] PTC Therapeutics ...
Pharmabiz5h
Hyderabad’s healthcare experts welcome UNGA's decision to reduce human deaths from AMR by 10% by 2030
Hyderabad’s healthcare experts welcome UNGA's decision to reduce human deaths from AMR by 10% by 2030: Our Bureau, Mumbai Saturday, September 28, 2024, 15:15 Hrs [IST] Hyderabad ...
Pharmabiz6h
Orion Corporation’s partner Bayer submits sNDA to US FDA for oral androgen receptor inhibitor darolutamide
Orion Corporation’s partner Bayer submits sNDA to US FDA for oral androgen receptor inhibitor darolutamide: Espoo, Finland Saturday, September 28, 2024, 15:00 Hrs [IST] Finnish ...
Pharmabiz7h
Our vision is a cancer-free future generation, where everyone has access to accurate tests and affordable treatment: Meghalaya health minister
Our Bureau, Mumbai Saturday, September 28, 2024, 13:30 Hrs [IST] ...
Pharmabiz1d
WHO releases guidance to improve the design, conduct and oversight of clinical trials
The World Health Organization (WHO) released guidance to improve the design, conduct and oversight of clinical trials in countries of all income levels. This guidance aims to support stronger ...
Pharmabiz1h
CK Birla Hospitals unveils ‘Every Beat Counts’ report: A first-of-its-kind insight into India’s cardiac health crisis
BM Birla Heart Hospital (BMB), part of CK Birla Hospitals, has launched a first of its kind report on India’s cardiac health – ‘Every Beat Counts’. This report not only sheds light on the cardiac ...
Pharmabiz6h
BFI partners with CSIR- CDRI to advance biomedical innovation
BFI partners with CSIR- CDRI to advance biomedical innovation: Our Bureau, Mumbai Saturday, September 28, 2024, 14:45 Hrs [IST] CSIR-Central Drug Research Institute (CDRI), a prem ...
Pharmabiz7h
World leaders commit to decisive action on antimicrobial resistance
World leaders commit to decisive action on antimicrobial resistance: Geneva Saturday, September 28, 2024, 14:00 Hrs [IST] Global leaders have approved a political declaration at t ...
Pharmabiz7h
Corning launches rabies awareness campaign with Serum Institute and SEWA India on World Rabies Day
Corning launches rabies awareness campaign with Serum Institute and SEWA India on World Rabies Day: Our Bureau, Mumbai Saturday, September 28, 2024, 13:45 Hrs [IST] Corning Incorp ...
Pharmabiz8h
Omeicos Therapeutics completes enrollment in phase 2a PMD-OPTION study of OMT-28 in primary mitochondrial disease
Omeicos Therapeutics completes enrollment in phase 2a PMD-OPTION study of OMT-28 in primary mitochondrial disease: Berlin, Germany Saturday, September 28, 2024, 13:00 Hrs [IST] Om ...
Pharmabiz11h
Pharming gets UK MHRA marketing authorization for Joenja to treat activated phosphoinositide 3-kinase delta (PI3Kd) syndrome
Pharming gets UK MHRA marketing authorization for Joenja to treat activated phosphoinositide 3-kinase delta (PI3Kd) syndrome: Leiden, the Netherlands Saturday, September 28, 2024, ...